• Patent Title: CRYSTALLINE PYRIMIDINYL-3,8-DIAZABICYCLO[3.2.1]OCTANYLMETHANONE COMPOUND AND USE THEREOF
  • Application No.: US17430373
    Application Date: 2020-02-12
  • Publication No.: US20220144846A1
    Publication Date: 2022-05-12
  • Inventor: Xiaojing YANGAmanda Patrice Surajhie SAMUEL
  • Applicant: Pfizer Inc.
  • Applicant Address: US NY New York
  • Assignee: Pfizer Inc.
  • Current Assignee: Pfizer Inc.
  • Current Assignee Address: US NY New York
  • International Application: PCT/IB2020/051128 WO 20200212
  • Main IPC: C07D487/08
  • IPC: C07D487/08
CRYSTALLINE PYRIMIDINYL-3,8-DIAZABICYCLO[3.2.1]OCTANYLMETHANONE COMPOUND AND USE THEREOF
Abstract:
The present invention discloses a novel crystalline form of ((S)-2,2-difluorocyclopropyl)-((1R,5S)-3-(2-((1-methyl-1H-pyrazol-4-yl)amino)-pyrimidin-4-yl)-3,8-diazabicyclo[3.2.1]octan-8-yl)methanone free base, pharmaceutical composition containing the same, preparations thereof and uses thereof.
Information query
Patent Agency Ranking
0/0